Akoya Biosciences, Inc.
AKYA
$1.27
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 22.16% | 19.90% | 44.01% | -117.40% | 16.37% |
| Total Depreciation and Amortization | 1.48% | -5.24% | -6.09% | -2.61% | -18.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 55.38% | -53.65% | -55.01% | 110.00% | -3.40% |
| Change in Net Operating Assets | 121.19% | 36.96% | 53.89% | -653.67% | 85.96% |
| Cash from Operations | 67.78% | 16.17% | 46.98% | -272.92% | 59.40% |
| Capital Expenditure | -140.09% | -155.29% | 79.01% | -36.36% | 28.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -72.24% | 45.85% | 119.21% | -- | -- |
| Cash from Investing | -79.31% | 43.79% | 118.55% | -8,118.35% | 28.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -202.41% | 4.05% | 4.42% | -0.56% | -2.86% |
| Issuance of Common Stock | 0.00% | -30.43% | -36.11% | 414.29% | -79.41% |
| Repurchase of Common Stock | -- | 100.00% | 56.38% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -1,173.33% | -- | -- |
| Cash from Financing | -224.00% | 92.94% | -378.60% | -104.01% | 7,956.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -121.45% | 187.86% | 94.13% | -1,530.60% | 133.27% |